International Partners, institutions and numerous countries have rallied together to support the COVID-19 Technology Access Pool or C-TAP to produce vaccines, tests, treatments and other health technologies to combat the coronavirus pandemic. This pool was initially proposed back in March by President Carlos Alvarado of Costa Rico. He joined the WHO Director-General Dr Tedros Adhanom Ghebreyesus at the official launch of the initiative today. “The COVID-19 Technology Access Pool will ensure the latest and best science benefits all of humanity,” said President Alvarado of Costa Rica. “Vaccines, tests, diagnostics, treatments and other key tools in the coronavirus response must be made universally available as global public goods”.
“Global solidarity and collaboration are essential to overcoming COVID-19,” said WHO Director-General Dr Tedros Adhanom Ghebreyesus. “Based on strong science and open collaboration, this information-sharing platform will help provide equitable access to life-saving technologies around the world.”
The C-TAP is voluntary and provide a one-stop shop for all scientific knowledge, data and intellectual property shared equally by the global community. Open science research, product development with additional manufacturing capacities will aid in this.
Five elements to the initiative comprise of public disclosure of gene sequences and data, transparency on all publications of clinical trial results, clauses by funders and governments with pharmaceutical companies, including innovators on equitable distribution and affordability within the publication of trial data. Licensing potential treatments and promotion of open innovation models and technology transfer will increase local manufacturing and supply capacity through the Open Covid Pledge.